Send PM
Followers 21
Posts 1812
Boards Moderated 0
Alias Born 09/11/2008


Re: None

Monday, 04/11/2022 10:10:21 PM

Monday, April 11, 2022 10:10:21 PM

Post# of 814
Matinas Biopharma News
Matinas Biopharma News

0.1533 (19.73%)
Upgrade to Real-Time
Afterhours (Closed)
Keep BUYIN till our MTNB reachin $3. Good news today !
Good Luck for everyone hanging on with MTNB for so long!

H.C. Wainwright Sticks to Its BUY Rating for Matinas BioPharma (MTNB)
April 11 2022 - 11:05AM

In a report released today, Andrew Fein from H.C. Wainwright reiterated a Buy rating on Matinas BioPharma (MTNB – Research Report), with a price target of $3.00. The company's shares closed last Monday at $0.79.

According to TipRanks.com, Fein has 0 stars on 0-5 stars ranking scale with an average return of -5.3% and a 37.8% success rate. Fein covers the Healthcare sector, focusing on stocks such as DBV Technologies SA - American, Amylyx Pharmaceuticals Inc, and Deciphera Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Matinas BioPharma with a $3.00 average price target.

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTNB News